Oxford BioMedica PLC (LSE:OXB) - Overview

Stock Report

Oxford BioMedica PLC OXB

Last Price
GBX3.85

Day Change
0.38|10.79%

As of 05/12/2016
17:15:06 GMT | GBX
Minimum 15 Minutes Delay.

Last Close3.48p
Day Range3.40 - 4.10
Mkt Cap118.90Mil
52-Wk Range2.98 - 8.45
Yield %0.00
ISINGB0006648157
Volume18,599,304
P/E-7.56
P/S6.22
P/CF-7.56

Share Price

Total Returns 05/12/2016

 Chg (%)  
More ...
Oxford BioMedica PLC8.45 
FTSE 100 TR GBP1.22
 
Financials
201320142015
More ...
Income Statement
Turnover5.3813.6215.91
Operating Profit-12.82-10.61-14.08
Net Profit-11.10-8.66-13.02
Reported EPS-0.79-0.43-0.51
Balance Sheet
Current Assets6.9422.7625.71
Non Current Assets6.7011.0526.14
Total Assets13.6433.8151.85
Current Liabilities4.219.2313.17
Total Liabilities4.7510.7740.96
Total Equity8.9023.0410.89
Cash Flow
Operating Cash Flow-13.01-7.43-14.87
Net Change in Cash-6.7912.03-4.84
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2016-15.55-0.40--9.53---
2017-7.57-0.12--31.56---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
02/12/2016PurchaseMr. Martin Diggle3.574,082,333145,739.00
25/11/2016PurchaseDr. Lorenzo Tallarigo3.5075,4172,640.00
25/10/2016PurchaseDr. Lorenzo Tallarigo3.4077,8642,647.00
04/10/2016PurchaseDr. Andrew Heath0.00200,0000.00

Company Profile

Oxford BioMedica PLC is a biopharmaceutical company. It develops gene-based medicines and therapeutic vaccines that improves the lives of patients with high unmet medical needs.
 

Sector

Biotechnology

Market Position

827 of 1864 Companies

Index

FTSE Small Cap ,FTSE All Share ,FTSE techMARK Focus ,FTSE techMARK All Share

Outlook

(13/09/2016) no outlook statement

Next Event 31/12/2016

Next year end (to be reported)
Ratios
CompSecMkt
More ...
PER (E)-27.1013.5916.10
Div Yld (E)0.004.234.35
PEG (E)0.000.550.19
ROCE-40.80209.79-30.25
Op Mrgn-94.89-15.64-33.57
EPS Grwth0.008.6822.86
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy0
Hold1
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Lorenzo Tallarigo
Chief Executive OfficerJohn Dawson
Chief Financial Officer & Co SecTim Watts
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at Trafford House, Chester Road, Manchester M32 0RS. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2016 Morningstar. All rights reserved.